176 related articles for article (PubMed ID: 35745838)
1. Effectiveness and Nephrotoxicity of Loading Dose Colistin-Meropenem versus Loading Dose Colistin-Imipenem in the Treatment of Carbapenem-Resistant
Katip W; Oberdorfer P; Kasatpibal N
Pharmaceutics; 2022 Jun; 14(6):. PubMed ID: 35745838
[TBL] [Abstract][Full Text] [Related]
2. The effectiveness and nephrotoxicity of loading dose colistin combined with or without meropenem for the treatment of carbapenem-resistant A. baumannii.
Katip W; Uitrakul S; Oberdorfer P
Int J Infect Dis; 2020 Aug; 97():391-395. PubMed ID: 32502665
[TBL] [Abstract][Full Text] [Related]
3. Clinical Efficacy and Nephrotoxicity of the Loading Dose Colistin for the Treatment of Carbapenem-Resistant
Katip W; Uitrakul S; Oberdorfer P
Pharmaceutics; 2021 Dec; 14(1):. PubMed ID: 35056926
[TBL] [Abstract][Full Text] [Related]
4. A Comparison of Colistin versus Colistin Plus Meropenem for the Treatment of Carbapenem-Resistant
Katip W; Uitrakul S; Oberdorfer P
Antibiotics (Basel); 2020 Sep; 9(10):. PubMed ID: 32998187
[TBL] [Abstract][Full Text] [Related]
5. High-Loading-Dose Colistin with Nebulized Administration for Carbapenem-Resistant
Katip W; Rayanakorn A; Sornsuvit C; Wientong P; Oberdorfer P; Taruangsri P; Nampuan T
Antibiotics (Basel); 2024 Mar; 13(3):. PubMed ID: 38534721
[TBL] [Abstract][Full Text] [Related]
6. Clinical Outcomes and Safety of Meropenem-Colistin versus Meropenem-Tigecycline in Patients with Carbapenem-Resistant
Park JM; Yang KS; Chung YS; Lee KB; Kim JY; Kim SB; Sohn JW; Yoon YK
Antibiotics (Basel); 2021 Jul; 10(8):. PubMed ID: 34438953
[TBL] [Abstract][Full Text] [Related]
7. Clinical Efficacy and Nephrotoxicity of Colistin Alone versus Colistin Plus Vancomycin in Critically Ill Patients Infected with Carbapenem-Resistant
Katip W; Oberdorfer P
Pharmaceutics; 2021 Jan; 13(2):. PubMed ID: 33530483
[No Abstract] [Full Text] [Related]
8.
Soudeiha MAH; Dahdouh EA; Azar E; Sarkis DK; Daoud Z
Front Cell Infect Microbiol; 2017; 7():209. PubMed ID: 28596943
[TBL] [Abstract][Full Text] [Related]
9. Short-Course Versus Long-Course Colistin for Treatment of Carbapenem-Resistant
Katip W; Uitrakul S; Oberdorfer P
Antibiotics (Basel); 2021 Apr; 10(5):. PubMed ID: 33922151
[TBL] [Abstract][Full Text] [Related]
10. Individual or Combined Effects of Meropenem, Imipenem, Sulbactam, Colistin, and Tigecycline on Biofilm-Embedded Acinetobacter baumannii and Biofilm Architecture.
Wang YC; Kuo SC; Yang YS; Lee YT; Chiu CH; Chuang MF; Lin JC; Chang FY; Chen TL
Antimicrob Agents Chemother; 2016 Aug; 60(8):4670-6. PubMed ID: 27216052
[TBL] [Abstract][Full Text] [Related]
11. Dose Optimization of Colistin Combinations against Carbapenem-Resistant Acinetobacter baumannii from Patients with Hospital-Acquired Pneumonia in China by Using an
Bian X; Liu X; Chen Y; Chen D; Li J; Zhang J
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745385
[TBL] [Abstract][Full Text] [Related]
12. Short versus long course of colistin treatment for carbapenem-resistant A. baumannii in critically ill patients: A propensity score matching study.
Katip W; Rayanakorn A; Oberdorfer P; Taruangsri P; Nampuan T
J Infect Public Health; 2023 Aug; 16(8):1249-1255. PubMed ID: 37295057
[TBL] [Abstract][Full Text] [Related]
13. Synergistic killing by meropenem and colistin combination of carbapenem-resistant Acinetobacter baumannii isolates from Chinese patients in an in vitro pharmacokinetic/pharmacodynamic model.
Liu X; Zhao M; Chen Y; Bian X; Li Y; Shi J; Zhang J
Int J Antimicrob Agents; 2016 Nov; 48(5):559-563. PubMed ID: 27670371
[TBL] [Abstract][Full Text] [Related]
14. Colistin plus Sulbactam or Fosfomycin against Carbapenem-Resistant
Saelim W; Changpradub D; Thunyaharn S; Juntanawiwat P; Nulsopapon P; Santimaleeworagun W
Infect Chemother; 2021 Mar; 53(1):128-140. PubMed ID: 34409786
[TBL] [Abstract][Full Text] [Related]
15. High-dose colistin for microbiologically documented serious respiratory infections associated with carbapenem-resistant Acinetobacter baummannii in critically ill cancer patients: a retrospective cohort study.
Nazer LH; Rihani S; Hawari FI; Le J
Infect Dis (Lond); 2015; 47(11):755-60. PubMed ID: 26050703
[TBL] [Abstract][Full Text] [Related]
16. Comparative evaluation of intratracheal colistimethate sodium, imipenem, and meropenem in BALB/c mice with carbapenem-resistant Acinetobacter baumannii pneumonia.
Tang HJ; Chuang YC; Ko WC; Chen CC; Shieh JM; Chen CH; Lee NY; Chiang SR
Int J Infect Dis; 2012 Jan; 16(1):e34-40. PubMed ID: 22088863
[TBL] [Abstract][Full Text] [Related]
17. Colistin Monotherapy versus Colistin plus Meropenem Combination Therapy for the Treatment of Multidrug-Resistant
Huang C; Chen I; Tang T
J Clin Med; 2022 Jun; 11(11):. PubMed ID: 35683622
[TBL] [Abstract][Full Text] [Related]
18. Comparative in vitro antimicrobial susceptibilities and synergistic activities of antimicrobial combinations against carbapenem-resistant Acinetobacter species: Acinetobacter baumannii versus Acinetobacter genospecies 3 and 13TU.
Sheng WH; Wang JT; Li SY; Lin YC; Cheng A; Chen YC; Chang SC
Diagn Microbiol Infect Dis; 2011 Jul; 70(3):380-6. PubMed ID: 21558048
[TBL] [Abstract][Full Text] [Related]
19. Treatment Outcomes of Colistin- and Carbapenem-resistant Acinetobacter baumannii Infections: An Exploratory Subgroup Analysis of a Randomized Clinical Trial.
Dickstein Y; Lellouche J; Ben Dalak Amar M; Schwartz D; Nutman A; Daitch V; Yahav D; Leibovici L; Skiada A; Antoniadou A; Daikos GL; Andini R; Zampino R; Durante-Mangoni E; Mouton JW; Friberg LE; Dishon Benattar Y; Bitterman R; Neuberger A; Carmeli Y; Paul M;
Clin Infect Dis; 2019 Aug; 69(5):769-776. PubMed ID: 30462182
[TBL] [Abstract][Full Text] [Related]
20. Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial.
Paul M; Daikos GL; Durante-Mangoni E; Yahav D; Carmeli Y; Benattar YD; Skiada A; Andini R; Eliakim-Raz N; Nutman A; Zusman O; Antoniadou A; Pafundi PC; Adler A; Dickstein Y; Pavleas I; Zampino R; Daitch V; Bitterman R; Zayyad H; Koppel F; Levi I; Babich T; Friberg LE; Mouton JW; Theuretzbacher U; Leibovici L
Lancet Infect Dis; 2018 Apr; 18(4):391-400. PubMed ID: 29456043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
